Logos Global Management LP Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$500.5B
Holdings
46
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (46 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —FORMA THERAPEUTICS HLDGS INC | 1,280,000 | $59.5B | 11.89% | |
| 2 | RETAEURREATA PHARMACEUTICALS INC | 200,000 | $31.2B | 6.24% | |
| 3 | TCE2CELLDEX THERAPEUTICS INC NEW | 2,000,000 | $26.0B | 5.20% | |
| 4 | RNAAVIDITY BIOSCIENCES INC | 926,454 | $25.6B | 5.11% | |
| 5 | RPTXREPARE THERAPEUTICS INC | 666,894 | $20.3B | 4.05% | |
| 6 | BNTXBIONTECH SE | 295,000 | $19.7B | 3.93% | |
| 7 | CYTKCYTOKINETICS INC | 800,000 | $18.9B | 3.77% | |
| 8 | ARNAEURARENA PHARMACEUTICALS INC | 268,500 | $16.9B | 3.38% | |
| 9 | —APPLIED MOLECULAR TRANS INC | 664,186 | $16.7B | 3.34% | |
| 10 | TGTXTG THERAPEUTICS INC | 850,000 | $16.6B | 3.31% | |
| 11 | AKBAAKEBIA THERAPEUTICS INC | 1,200,000 | $16.3B | 3.26% | |
| 12 | BTAIEURBIOXCEL THERAPEUTICS INC | 300,000 | $15.9B | 3.18% | |
| 13 | IMVTIMMUNOVANT INC | 625,000 | $15.2B | 3.04% | |
| 14 | KROSKEROS THERAPEUTICS INC | 400,000 | $15.0B | 3.00% | |
| 15 | PLRXPLIANT THERAPEUTICS INC | 456,426 | $14.6B | 2.91% | |
| 16 | PCVXVAXCYTE INC | 455,000 | $14.4B | 2.87% | |
| 17 | BMY-RBRISTOL-MYERS SQUIBB CO | 4,000,000 | $14.3B | 2.86% | |
| 18 | —ZOGENIX INC | 400,000 | $10.8B | 2.16% | |
| 19 | —AKOUOS INC | 450,000 | $10.1B | 2.02% | |
| 20 | —PRINCIPIA BIOPHARMA INC | 150,000 | $9.0B | 1.79% | |
| 21 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 135,000 | $8.5B | 1.70% | |
| 22 | PASGPASSAGE BIO INC | 344,438 | $8.5B | 1.69% | |
| 23 | FULCFULCRUM THERAPEUTICS INC | 410,000 | $7.5B | 1.50% | |
| 24 | —CALLIDITAS THERAPEUTICS AB | 300,000 | $7.0B | 1.40% | |
| 25 | —OBSEVA SA | 1,165,000 | $6.9B | 1.37% | |
| 26 | GBIOGBXGENERATION BIO CO | 325,000 | $6.8B | 1.36% | |
| 27 | KALVKALVISTA PHARMACEUTICALS INC | 562,900 | $6.8B | 1.36% | |
| 28 | 1K0IGM BIOSCIENCES INC | 91,841 | $6.7B | 1.34% | |
| 29 | BLUBELLUS HEALTH INC NEW | 600,000 | $6.2B | 1.23% | |
| 30 | ETNBGBP89BIO INC | 290,000 | $5.8B | 1.15% | |
| 31 | —APTOSE BIOSCIENCES INC | 750,000 | $4.7B | 0.95% | |
| 32 | BDTXBLACK DIAMOND THERAPEUTICS I | 123,465 | $4.7B | 0.94% | |
| 33 | SWTXSPRINGWORKS THERAPEUTICS INC | 110,000 | $4.6B | 0.92% | |
| 34 | OPHTEURIVERIC BIO INC | 900,000 | $4.6B | 0.92% | |
| 35 | RAPTEURRAPT THERAPEUTICS INC | 155,000 | $4.5B | 0.90% | |
| 36 | —LIFESCI ACQUISITION CORP | 400,000 | $4.4B | 0.88% | |
| 37 | RCKTROCKET PHARMACEUTICALS INC | 150,000 | $3.1B | 0.63% | |
| 38 | STROSUTRO BIOPHARMA INC | 361,945 | $2.8B | 0.56% | |
| 39 | —FUSION PHARMACEUTICALS INC | 121,128 | $2.1B | 0.42% | |
| 40 | —CHARDAN HEALTHCR ACQSTN 2 CO | 200,000 | $2.1B | 0.42% | |
| 41 | ASNSUSDX4 PHARMACEUTICALS INC | 158,484 | $1.5B | 0.30% | |
| 42 | —ARYA SCIENCES ACQUISTION CO | 100,000 | $1.2B | 0.23% | |
| 43 | 4NX1LUMOS PHARMA INC | 50,000 | $825.0M | 0.16% | |
| 44 | LRMRLARIMAR THERAPEUTICS INC | 57,475 | $739.0M | 0.15% | |
| 45 | MREOMEREO BIOPHARMA GROUP PLC | 200,000 | $612.0M | 0.12% | |
| 46 | APLTAPPLIED THERAPEUTICS INC | 12,600 | $455.0M | 0.09% |